Literature DB >> 9632609

Cytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells.

M D Island1, X Cui, B Foxman, C F Marrs, W E Stamm, A E Stapleton, J W Warren.   

Abstract

Approximately one-half of Escherichia coli isolates from patients with cystitis or pyelonephritis produce the pore-forming cytotoxin hemolysin, a molecule with the capacity to lyse erythrocytes and a range of nucleated cell types. A second toxin, cytotoxic necrotizing factor 1 (CNF1), is found in approximately 70% of hemolytic, but rarely in nonhemolytic, isolates. To evaluate the potential interplay of these two toxins, we used epidemiological and molecular biologic techniques to compare the cytotoxicity of hemolytic, CNF1(+), and CNF1(-) cystitis strains toward human T24 bladder epithelial cells in vitro. A total of 29 isolates from two collections of cystitis-associated E. coli were evaluated by using methylene blue staining of bladder monolayers at 1-h intervals after inoculation with each strain. Most (20 of 29) isolates damaged or destroyed the T24 monolayer (less than 50% remaining) within 4 h after inoculation. As a group, CNF1(+) isolates from one collection (11 strains) were less cytotoxic at 4 h than the CNF1(-) strains in that collection (P = 0.009), but this pattern was not observed among isolates from the second collection (18 strains). To directly evaluate the role of CNF1 in cytotoxicity of hemolytic E. coli without the variables present in multiple clinical isolates, we constructed mutants defective in production of CNF1. Compared to the CNF1(+) parental isolates, no change in cytotoxicity was detected in these cnf1 mutants. Our results indicate that CNF1 does not have a detectable effect on the ability of hemolytic E. coli to damage human bladder cell monolayers in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632609      PMCID: PMC108356     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase.

Authors:  S Y Pérès; O Marchès; F Daigle; J P Nougayrède; F Herault; C Tasca; J De Rycke; E Oswald
Journal:  Mol Microbiol       Date:  1997-06       Impact factor: 3.501

2.  Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.

Authors:  P O'Hanley; G Lalonde; G Ji
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 3.  Management of urinary tract infections in adults.

Authors:  W E Stamm; T M Hooton
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

Review 4.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli.

Authors:  J De Rycke; E A González; J Blanco; E Oswald; M Blanco; R Boivin
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

6.  Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection.

Authors:  B Foxman; L Zhang; K Palin; P Tallman; C F Marrs
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

7.  Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.

Authors:  S J Cavalieri; I S Snyder
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

8.  An improved suicide vector for construction of chromosomal insertion mutations in bacteria.

Authors:  R J Penfold; J M Pemberton
Journal:  Gene       Date:  1992-09-01       Impact factor: 3.688

9.  Virulence factors of bacteraemic Escherichia coli with particular reference to production of cytotoxic necrotising factor (CNF) by P-fimbriate strains.

Authors:  J Blanco; M P Alonso; E A González; M Blanco; J I Garabal
Journal:  J Med Microbiol       Date:  1990-03       Impact factor: 2.472

10.  Production of enterotoxin, verotoxin, hemolysin and cytotoxic necrotizing factor by Escherichia coli of intestinal and extraintestinal origin.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

View more
  10 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

2.  Lack of a role of cytotoxic necrotizing factor 1 toxin from Escherichia coli in bacterial pathogenicity and host cytokine response in infected germfree piglets.

Authors:  S Fournout; C M Dozois; M Odin; C Desautels; S Pérès; F Hérault; F Daigle; C Segafredo; J Laffitte; E Oswald; J M Fairbrother; I P Oswald
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.

Authors:  Yarery C Smith; Kerian K Grande; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

Authors:  S J Drews; S M Poutanen; T Mazzulli; A J McGeer; A Sarabia; S Pong-Porter; Y Rzayev; B Willey; K Green; D E Low
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells.

Authors:  Karellen Beren García Méndez; Gabriel Bragagnolo; David O'Callaghan; Jean-Philippe Lavigne; Anne Keriel
Journal:  Int J Exp Pathol       Date:  2016-06-08       Impact factor: 1.925

6.  Occurrence and genetic association of selected virulence factors in clinical Escherichia coli isolates.

Authors:  E Bogyiová; L Siegfried; M Kmetová; Z Sándorcínová; A Liptáková; E Biros
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

7.  Effect of Escherichia coli cytotoxic necrotizing factor 1 on repair of human bladder cell monolayers in vitro.

Authors:  M D Island; X Cui; J W Warren
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Enteroaggregative and cell-detaching Escherichia coli strains among Polish children with and without diarrhea.

Authors:  B M Sobieszczańska; J Osek
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

9.  Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells.

Authors:  Lise Crémet; Alexis Broquet; Bénédicte Brulin; Cédric Jacqueline; Sandie Dauvergne; Régis Brion; Karim Asehnoune; Stéphane Corvec; Dominique Heymann; Nathalie Caroff
Journal:  Pathog Dis       Date:  2015-09-01       Impact factor: 3.166

10.  Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.

Authors:  Jason E Michaud; Kwang Sik Kim; William Harty; Matthew Kasprenski; Ming-Hsien Wang
Journal:  BMC Microbiol       Date:  2017-05-25       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.